{"id":"https://openalex.org/W1992892003","doi":"https://doi.org/10.1016/s0028-3908(98)00224-x","title":"Characterization of quinolone antibacterial-induced convulsions and increases in nuclear AP-1 DNA- and CRE-binding activities in mouse brain","display_name":"Characterization of quinolone antibacterial-induced convulsions and increases in nuclear AP-1 DNA- and CRE-binding activities in mouse brain","publication_year":1999,"publication_date":"1999-05-01","ids":{"openalex":"https://openalex.org/W1992892003","doi":"https://doi.org/10.1016/s0028-3908(98)00224-x","mag":"1992892003","pmid":"https://pubmed.ncbi.nlm.nih.gov/10340309"},"language":"en","primary_location":{"id":"doi:10.1016/s0028-3908(98)00224-x","doi":"https://doi.org/10.1016/s0028-3908(98)00224-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0028-3908(98)00224-x","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074545551","display_name":"Yoshihisa Ito","orcid":"https://orcid.org/0000-0002-1835-7783","observed_orcids":["https://orcid.org/0000-0002-1835-7783"]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshihisa Ito","raw_affiliation_strings":["Department of Pharmacology, College of Pharmacy, Nihon University, Chiba, Japan. yoshii@pha.nihon-u.ac.jp","Department of Pharmacology, College of Pharmacy, Nihon University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, College of Pharmacy, Nihon University, Chiba, Japan. yoshii@pha.nihon-u.ac.jp","institution_ids":["https://openalex.org/I104946051"]},{"raw_affiliation_string":"Department of Pharmacology, College of Pharmacy, Nihon University, Chiba, Japan","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062627222","display_name":"Kumiko Ishige","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kumiko Ishige","raw_affiliation_strings":["Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061301598","display_name":"Masahiro Aizawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Aizawa","raw_affiliation_strings":["Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106182791","display_name":"Hideomi Fukuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideomi Fukuda","raw_affiliation_strings":["Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan","institution_ids":["https://openalex.org/I104946051"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074545551"],"corresponding_institution_ids":["https://openalex.org/I104946051"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":0.7144,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.68087421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"38","issue":"5","first_page":"717","last_page":"723"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quinolones","display_name":"quinolones","score":0.9269999861717224},{"id":"https://openalex.org/keywords/drug-induced-seizures","display_name":"drug-induced seizures","score":0.7680000066757202},{"id":"https://openalex.org/keywords/enoxacin","display_name":"enoxacin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/norfloxacin","display_name":"norfloxacin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/levofloxacin","display_name":"levofloxacin","score":0.878000020980835},{"id":"https://openalex.org/keywords/ofloxacin","display_name":"ofloxacin","score":0.8370000123977661},{"id":"https://openalex.org/keywords/activator-protein-1","display_name":"activator protein-1","score":0.828000009059906},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.6370000243186951},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":1.0},{"id":"https://openalex.org/keywords/seizures","display_name":"seizures","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C2776072828","wikidata":"https://www.wikidata.org/wiki/Q1639616","display_name":"Enoxacin","level":5,"score":0.78525710105896},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6645232439041138},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6637155413627625},{"id":"https://openalex.org/C2778746504","wikidata":"https://www.wikidata.org/wiki/Q417897","display_name":"Norfloxacin","level":4,"score":0.5720283389091492},{"id":"https://openalex.org/C2779922871","wikidata":"https://www.wikidata.org/wiki/Q426549","display_name":"Quinolone","level":3,"score":0.5594761967658997},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.47625088691711426},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28251564502716064},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17465001344680786},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.17247942090034485},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.15695896744728088},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.05864107608795166}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002373","descriptor_name":"Cyclic AMP Receptor Protein","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D002373","descriptor_name":"Cyclic AMP Receptor Protein","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009643","descriptor_name":"Norfloxacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010648","descriptor_name":"Phenylacetates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015365","descriptor_name":"Enoxacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018808","descriptor_name":"Transcription Factor AP-1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018808","descriptor_name":"Transcription Factor AP-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0028-3908(98)00224-x","doi":"https://doi.org/10.1016/s0028-3908(98)00224-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0028-3908(98)00224-x","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:10340309","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10340309","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W253691708","https://openalex.org/W1498554246","https://openalex.org/W1592320203","https://openalex.org/W1975784530","https://openalex.org/W1980962295","https://openalex.org/W1983909621","https://openalex.org/W1985460572","https://openalex.org/W1994421395","https://openalex.org/W1999225119","https://openalex.org/W2002086478","https://openalex.org/W2002783902","https://openalex.org/W2012498956","https://openalex.org/W2015023324","https://openalex.org/W2027195002","https://openalex.org/W2028022540","https://openalex.org/W2031649732","https://openalex.org/W2032216014","https://openalex.org/W2032247032","https://openalex.org/W2039802900","https://openalex.org/W2048429943","https://openalex.org/W2052977964","https://openalex.org/W2055498000","https://openalex.org/W2064856877","https://openalex.org/W2064958031","https://openalex.org/W2072711064","https://openalex.org/W2074058851","https://openalex.org/W2081304551","https://openalex.org/W2084192998","https://openalex.org/W2087075260","https://openalex.org/W2107204517","https://openalex.org/W2153903729","https://openalex.org/W2156957213","https://openalex.org/W2240996803","https://openalex.org/W2340742662","https://openalex.org/W2410908559","https://openalex.org/W2414048980","https://openalex.org/W6671352294"],"related_works":["https://openalex.org/W3105383888","https://openalex.org/W2032379614","https://openalex.org/W2401080276","https://openalex.org/W2326406682","https://openalex.org/W2020065009","https://openalex.org/W2031725847","https://openalex.org/W1983909621","https://openalex.org/W2027195002","https://openalex.org/W2072711064","https://openalex.org/W2076474887"],"abstract_inverted_index":null,"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}